ATE226814T1 - Pharmazeutische zusammensetzung hergestellt durch zugabe eines geschmackstoff an einer wirkstoff - Google Patents

Pharmazeutische zusammensetzung hergestellt durch zugabe eines geschmackstoff an einer wirkstoff

Info

Publication number
ATE226814T1
ATE226814T1 AT96919786T AT96919786T ATE226814T1 AT E226814 T1 ATE226814 T1 AT E226814T1 AT 96919786 T AT96919786 T AT 96919786T AT 96919786 T AT96919786 T AT 96919786T AT E226814 T1 ATE226814 T1 AT E226814T1
Authority
AT
Austria
Prior art keywords
flavor
pharmaceutical composition
active ingredient
composition produced
produced
Prior art date
Application number
AT96919786T
Other languages
English (en)
Inventor
Philip Christopher Buxton
Janice Duncan
Wendy Johnson
Geoffrey David Tovey
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9510349.5A external-priority patent/GB9510349D0/en
Priority claimed from GBGB9604187.6A external-priority patent/GB9604187D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of ATE226814T1 publication Critical patent/ATE226814T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Seasonings (AREA)
AT96919786T 1995-05-23 1996-05-15 Pharmazeutische zusammensetzung hergestellt durch zugabe eines geschmackstoff an einer wirkstoff ATE226814T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9510349.5A GB9510349D0 (en) 1995-05-23 1995-05-23 Formulations
GBGB9604187.6A GB9604187D0 (en) 1996-02-28 1996-02-28 Flavouring system
PCT/EP1996/002144 WO1996037188A1 (en) 1995-05-23 1996-05-15 Pharmaceutical composition prepared by addition of a flavour vehicle to a medicament

Publications (1)

Publication Number Publication Date
ATE226814T1 true ATE226814T1 (de) 2002-11-15

Family

ID=26307069

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96919786T ATE226814T1 (de) 1995-05-23 1996-05-15 Pharmazeutische zusammensetzung hergestellt durch zugabe eines geschmackstoff an einer wirkstoff

Country Status (17)

Country Link
US (1) US6428808B1 (de)
EP (1) EP0827393B1 (de)
JP (1) JP4128622B2 (de)
KR (1) KR19990021841A (de)
CN (1) CN1190887A (de)
AT (1) ATE226814T1 (de)
AU (1) AU5819296A (de)
BR (1) BR9609051A (de)
CA (1) CA2219824A1 (de)
CZ (1) CZ369297A3 (de)
DE (1) DE69624563T2 (de)
ES (1) ES2185776T3 (de)
HU (1) HUP9802302A2 (de)
NO (1) NO975371D0 (de)
PL (1) PL323496A1 (de)
TR (1) TR199701410T1 (de)
WO (1) WO1996037188A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU708501B3 (en) * 1998-09-04 1999-08-05 Australian Medical Research Centre Medication administration means and method of administering medication
WO2005044066A2 (en) * 2003-10-28 2005-05-19 Mcneil-Ppc, Inc. Filter with sweetener
US7371405B2 (en) * 2003-12-22 2008-05-13 Mcneil-Ppc, Inc. Consumer customized dosage forms
US20050136105A1 (en) * 2003-12-22 2005-06-23 Allen Marni L. Consumer customized dosage forms
US20070172552A1 (en) * 2006-01-17 2007-07-26 Davies Gary R Sweet-tea
US20090287144A1 (en) * 2007-02-15 2009-11-19 Kidkupz Llc Pediatric medicine dosage cup, tray, and fabrication method
WO2010096058A1 (en) * 2009-02-20 2010-08-26 Kidkupz Llc Pediatric medicine dosage cup, tray, and fabrication method
CN102313626B (zh) * 2011-03-28 2013-06-12 中国计量学院 液体式高速转子在线动平衡头
JP6896431B2 (ja) * 2017-01-10 2021-06-30 株式会社Ｓｃｒｅｅｎホールディングス 粒状物、読取装置、および印刷装置

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4071614A (en) * 1975-06-03 1978-01-31 Colgate Palmolive Company Dentifrice containing encapsulated flavoring
US4292028A (en) * 1979-07-13 1981-09-29 Arthur Barr Cosmetic breath freshener and palate coolant composition and method of use
EP0025269B1 (de) * 1979-08-23 1985-11-13 Beecham Group Plc Veterinärzusammensetzung gegen Diarrhöe
IT1204069B (it) * 1986-05-30 1989-03-01 Menarini Sas Utilizzazione della forma farmaceutica per uso orale di sali ferrosi impiegabili in terapia nelle forme di anemia da carenza di ferro
US5814337A (en) * 1992-10-07 1998-09-29 Beecham Group Plc Pharmaceutical formulation
US5817294A (en) * 1990-11-02 1998-10-06 Arnold; Michael J. Plaque adsorbent oral composition and method
FR2686064B1 (fr) * 1992-01-15 1995-04-21 Remy Deslandes Conteneur pour la consommation d'une dose de produit liquide.
US5716615A (en) * 1992-02-10 1998-02-10 Renata Maria Anna Cavaliere Vesely Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use
GB2270920B (en) * 1992-09-25 1997-04-02 Univ Keele Alginate-bioactive agent conjugates
US5560912A (en) * 1994-06-27 1996-10-01 Technion Research & Development Foundation Ltd. Method for inhibiting growth of helicobacter pylori
US5939447A (en) * 1996-01-04 1999-08-17 Smithkline Beecham Corporation Substituted benzopyrans
GB9700331D0 (en) * 1997-01-09 1997-02-26 Smithkline Beecham Plc Process
US6027746A (en) * 1997-04-23 2000-02-22 Warner-Lambert Company Chewable soft gelatin-encapsulated pharmaceutical adsorbates
TW546151B (en) * 1997-07-23 2003-08-11 Senju Pharma Co Aqueous liquid pharmaceutical composition containing as main component benzopyran derivative

Also Published As

Publication number Publication date
PL323496A1 (en) 1998-03-30
HUP9802302A2 (hu) 1999-02-01
WO1996037188A1 (en) 1996-11-28
EP0827393A1 (de) 1998-03-11
EP0827393B1 (de) 2002-10-30
TR199701410T1 (xx) 1998-03-21
JPH11505816A (ja) 1999-05-25
US6428808B1 (en) 2002-08-06
NO975371L (no) 1997-11-21
ES2185776T3 (es) 2003-05-01
JP4128622B2 (ja) 2008-07-30
MX9709001A (es) 1998-03-31
CN1190887A (zh) 1998-08-19
DE69624563T2 (de) 2003-06-18
CZ369297A3 (cs) 1998-05-13
NO975371D0 (no) 1997-11-21
CA2219824A1 (en) 1996-11-28
BR9609051A (pt) 1999-02-23
KR19990021841A (ko) 1999-03-25
DE69624563D1 (de) 2002-12-05
AU5819296A (en) 1996-12-11

Similar Documents

Publication Publication Date Title
DE58906926D1 (de) Neue Arzneimittelformulierung sowie Verfahren zu deren Herstellung.
NO20053105D0 (no) Oral, analgesisk doseringsform med forlenget frigivelse for administrering ±n gang pr. dag.
ES2160577T3 (es) Nuevos esteres de aminoalcoholes biciclicos y triciclicos, su preparacion y su utilizacion en medicamentos.
DE69001730D1 (de) Pastenfoermige, waesserige pharmazeutische zusammensetzungen.
DE69104991D1 (de) Mometason-furoate-monohydrat, verfahren zu seiner herstellung und das enthaltende pharmazeutische zusammensetzungen.
DE3860550D1 (de) Pharmazeutische zubereitung fuer perkutane verabreichung, die eperison oder tolperison oder eines ihrer salze enthaelt.
WO2001090091A8 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
EE200000329A (et) Oraalne manustamisvorm happes ebapüsivate toimeainete tarbeks, selle valmistamismeetod ja happes ebapüsivat toimeainet sisaldava toimeaineühiku kasutamine
IT1241996B (it) Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione.
CY1112139T1 (el) Μια φαρμακευτικη συνθεση περιλαμβανουσα κρυσταλλικη ριτοναβιρη μορφη ιι και ενα παρασκευασμα εξ αυτης
DE3483508D1 (de) Physiologisch aktive substanz k-252, verfahren zu ihrer herstellung und eine pharmazeutische zusammensetzung die diese enthaelt.
RU93004445A (ru) Новые 2-циано 3-гидроксиенамидные производные, способ их получения, их применение в качестве медикаментов, содержащие их фармацевтические композиции и новые полученные промежуточные продукты
DE69923336D1 (de) Oral anzuwendende buprenorphinhaltige arzneimittel
ATE499939T1 (de) Neue pharmazeutische zusammenstezungen, flibanserin polymorph a enthaltend
CA2280310A1 (en) Nmda antagonist
ATE226814T1 (de) Pharmazeutische zusammensetzung hergestellt durch zugabe eines geschmackstoff an einer wirkstoff
DK1171101T3 (da) Fremgangsmåde til fremstilling af en vanduoplöselig amorf depotmatrix
IL150528A0 (en) Ibuprofen containing active agent preparation
FR2663326B2 (fr) Derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant.
WO2000008007A3 (de) Cyclopentabenzofuran-derivate und ihre verwendung
EP0230264A3 (en) Pharmaceutical composition for nasal application, process for its preparation and its use
ATE245974T1 (de) Pharmazeutische zusammensetzungen, bestimmt zur oralen verabreichung von phloroglucinol sowie deren herstellung
HUP0004362A2 (hu) Karbamazepint vagy származékait tartalmazó parenterális készítmények
ATE234096T1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid
ATE136783T1 (de) Arzneimittel mit antineoplastischer wirkung enthaltend als wirkstoff octadecyl-(2-(n- methylpiperidino)-ethyl>-phosphat und verfahren zu dessen herstellung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties